New insider activity at Bio Green Med Solution ( (BGMS) ) has taken place on November 3, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Significant shareholders of Bio Green Med Solution have recently sold substantial amounts of stock. Khai Loon Kua sold 242,477 shares for $436,458, Kim Choy Yap sold 112,260 shares for $202,068, and Yee Lung Ong sold 248,814 shares for $447,865. These transactions highlight a notable shift in the holdings of key investors.
Recent Updates on BGMS stock
In recent developments, Bio Green Med Solution (BGMS) finalized an Asset Purchase Agreement with Tethra Biosciences Inc. on October 6, 2025, selling certain assets including patent rights related to Plogosertib for $300,000, with a potential milestone payment of $170,000. This strategic move signifies a shift in the company’s operations by transferring key intellectual property. Additionally, on October 7, 2025, BGMS announced a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock, payable on November 1, 2025. Despite these announcements, Spark, TipRanks’ AI Analyst, maintains an ‘Underperform’ rating on BGMS, citing the company’s financial strain, operational inefficiencies, and unattractive valuation due to a negative P/E ratio and lack of dividend yield. The overall technical sentiment remains a ‘Strong Sell’.
Spark’s Take on BGMS Stock
According to Spark, TipRanks’ AI Analyst, BGMS is a Underperform.
Cyclacel Pharmaceuticals is currently under significant financial strain, marked by operational inefficiencies and a weak financial position, as reflected in its low financial performance score. While the technical indicators suggest a neutral trend, the valuation is unattractive due to its negative P/E ratio and lack of dividend yield. These factors collectively result in a low overall stock score.
To see Spark’s full report on BGMS stock, click here.
More about Bio Green Med Solution
YTD Price Performance: -98.03%
Average Trading Volume: 500,079
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.99M